drugset
drugset / Trial / NCT01293357

A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects

NCT01293357 ↗

Phase 1 Completed 20 enrolled LEO Pharma Quintiles, Inc. · collab
NaSingle-groupSingle-blindOther

Summary

The objective of the trial is to investigate skin irritation, phototoxicity and safety of LEO 90105 and its components by patchtest (48 hours closed patch test and photo patch test) in healthy Japanese male subjects.

Timeline

Start
2010-12
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject LEO 90105 Unknown — Topical

Indications

No indication recorded.